TORONTO | Research published in the Journal of Experimental Medicine may provide a new avenue for the treatment of Acute Myeloid Leukemia (AML) and a solution to the high rate of disease relapse experienced by patients.
A diabetic woman from Ontario is speaking out about Canada’s provincial patchwork of health services, which prevented her from getting treatment in Alberta until she took matters into her own hands.